Stocks · Health care · Services-Medical Laboratories

Caris Life Sciences, Inc.

CAI Clue Score63
United States Fiscal year ends December CIK 0002019410 Results filed 4 Nov 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Jon Halbert
15 May 2026
Director
Buy indirect
68,000
$14.56
$990.08K
Jeff L Vacirca
11 May 2026
Director
Buy
31,050
$16.15
$501.43K
David Baxley Spetzler
7 Nov 2025
President
Buy
400
$23.85
$9.54K
John Russel Denton
7 Nov 2025
See Remarks
Buy indirect
4,184
$24.09
$100.79K
Brian J Brille
20 Jun 2025
See Remarks
Buy
30,000
$21.00
$630.00K
John Russel Denton
20 Jun 2025
See Remarks
Buy
7,500
$21.00
$157.50K

What was left out

Form 4 filings counted 50
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 4
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 6
Sales at will 1
Transactions with no price 0
Shares from compensation/vesting 162,091,278
History held since 23 Jun 2025